Q32 Bio (QTTB) Equity Ratio (2017 - 2026)

Q32 Bio has reported Equity Ratio for 10 years, with the latest figure at 0.73 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 1532.76% year-over-year to 0.73; the trailing twelve-month figure through Mar 2026 stood at 0.73 (up 1532.76% YoY), and the FY2025 full-year result was 0.68, up 1006.52% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.73, up from 0.68 in the prior quarter.
• The five-year high for Equity Ratio was 0.86 in Q1 2022, with the low at 3.89 in Q4 2023.
• Average Equity Ratio over 5 years is 0.17, with a median of 0.06 recorded in 2024.
• Year-over-year, Equity Ratio slumped 579.44% in 2023 and jumped 1532.76% in 2026.
• Tracing QTTB's Equity Ratio over 5 years: stood at 0.57 in 2022, then tumbled by 579.44% to 3.89 in 2023, then soared by 101.58% to 0.06 in 2024, then soared by 1006.52% to 0.68 in 2025, then increased by 6.94% to 0.73 in 2026.
• The last three Equity Ratio figures came in at 0.73 (Q1 2026), 0.68 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.

Peer Comparison